+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Plaque Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Plaque Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Moderate Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Moderate Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Lamellar Ichthyosis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Lamellar Ichthyosis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Ichthyosis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Ichthyosis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Genital Warts Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Genital Warts Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Bullous Pemphigoid Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Bullous Pemphigoid Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more